Both in Pharmaceuticals
Monopar Therapeutics vs Shattuck Labs
Over the past year MNPR returned −10.2% and STTK returned +158.1%; their daily moves had a correlation of 0.29.
MNPR −10.2% STTK +158.1%Growth of $1, one year, split-adjusted
| Metric | MNPR | STTK |
|---|---|---|
| Price | $69.27 | $5.42 |
| Market cap | $465.0M | $544.0M |
| Today | −3.52% | −1.99% |
| 1 month | −32.6% | −7.4% |
| 6 months | +23.2% | −28.0% |
| Year to date | +6.1% | +48.5% |
| 1 year | −23.4% | +206.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 544.0× |
| Net cash | $134.3M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 53.3% | 61.8% |
| Short % of float | 22.4% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).